top of page
Search

Permeation Enhancers in TDDS

  • Permeation enhancers improve skin permeability, facilitating drug delivery through the stratum corneum.

  • Selection depends on the drug, formulation, and desired absorption rate.

Chemical Enhancers

  • Compounds that reduce the skin's barrier function by interacting with stratum corneum lipids and proteins.

Mechanisms of Action

  • Lipid Interaction: Extracting or fluidizing skin lipids.

  • Protein Modification: Altering keratin structure.

  • Drug Solubility: Increasing solubility and partitioning.

Examples

  • Solvents: Ethanol, propylene glycol (lipid extraction).

  • Surfactants: Sodium lauryl sulfate, cetyl alcohol (lipid interaction).

  • Fatty Acids: Oleic acid, linoleic acid (lipid disruption).

  • Terpenes: Menthol, limonene (solubility enhancement).

Physicochemical Enhancers

  • Use physical forces or devices to enhance drug delivery.

Examples

  • Iontophoresis: Electric current drives charged drugs into the skin.

  • Sonophoresis: Ultrasound waves improve permeability.

  • Microneedles: Create microchannels in the skin for easier drug passage.

  • Electroporation: Short electric pulses form transient aqueous pores.

  • Magnetophoresis: Magnetic fields enhance drug permeation.

Ideal Properties of Permeation Enhancers

  1. Safety: Non-toxic, non-irritating.

  2. Reversible Action: Temporary barrier disruption.

  3. Low Concentration: Effective in small amounts.

  4. Non-Reactive: Stable with drugs and formulation components.

  5. Improves Solubility and Stability: Enhances drug compatibility.

  6. Rapid Onset: Quick action post-application.

  7. Sustained Effect: Duration aligns with drug delivery needs.

Key Considerations

Selecting a permeation enhancer requires understanding:

  • Drug Properties: Solubility, stability, lipophilicity.

  • Mechanisms of Action: Enhancer’s interaction with the skin.

  • Safety and Efficacy: Verified through rigorous trials.

Optimal enhancer selection ensures effective, safe, and efficient drug delivery in TDDS


bottom of page